A study of 34 cases of adrenal incidentaloma;Estudio de 34 pacientes con incidentaloma suprarrenal

Medicina

Volumn 67, Issue 4, 2007, Pages 341-350

  Chervin, Raul A ^a   Danilowicz, Karina ^b   Pitoia, Fabian ^b   Gomez, Reynaldo M ^b   Bruno, Oscar D ^b  

^a HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^b NONE

Author keywords

Adrenal gland tumors; Adrenal incidentaloma; Subclinical Cushing's syndrome

Indexed keywords

ANDROGEN; HYDROCORTISONE;

ADOLESCENT; ADRENAL CORTEX ADENOMA; ADRENAL CORTEX CARCINOMA; ADRENAL HYPERPLASIA; ADRENAL INCIDENTALOMA; ADULT; AGED; ANDROGEN RELEASE; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL DECISION MAKING; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CONGENITAL ADRENAL HYPERPLASIA; CONTROLLED STUDY; CUSHING SYNDROME; DIABETES MELLITUS; FEMALE; HISTOPLASMOSIS; HUMAN; HYDROCORTISONE RELEASE; HYPERTENSION; LIPOMA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHEOCHROMOCYTOMA; PRIMARY HYPERALDOSTERONISM; PSEUDOCYST; RETROSPECTIVE STUDY; TUMOR DIAGNOSIS;

ADENOMA; ADOLESCENT; ADRENAL GLAND NEOPLASMS; ADULT; AGE DISTRIBUTION; AGED; ANDROGENS; CHILD; CUSHING SYNDROME; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INCIDENTAL FINDINGS; MALE; MIDDLE AGED; PHEOCHROMOCYTOMA; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 34548506552     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Herrera MF, Grant CS, van Heerden JA, Sheedy PF, Ilstrup DM. Incidentally discovered adrenal tumors: an institutional perspective. Surgery 1991; 110: 1014-21.
2. Mansmann G, Lau J, Balk E, Tothberg M, Miyachi Y, Bornstein SR. The clinically inapparent adrenal mass: update in diagnosis and management. Endocrine Rev 2004; 25: 309-40.
3. Copeland PM. The incidentally discovered adrenal mass: an update. Endocrinologist 1999; 9: 415-23.
4. Mantero F, Terzolo M, Arnaldi G, et al. A survey on adrenal incidentaloma in Italy. J Clin Endocrinol Metab 2000; 85: 637-44.
5. Reinig JW, Doppman JL, Dwyer AJ, Frank J. MRI of indeterminate adrenal masses. AJR Amer J Roentgenol 1986 147: 493-6.
6. Gross MD, Falke THM, Shapiro B, Sandler MP. Adrenal gland. In: Sandler MP, Patton JA, Gross MD, Shapiro B, Falke THM (eds). Endocrine Imaging. Norwalk, Connecticut/San Mateo/California: Appleton & Lange, 1992, ch. 11, p 271-349.
7. Korobkin M, Francis IR, Kloos RT, Dunnick NR. The incidental adrenal mass. Radiol Clin North Am 1996; 34: 1037-55.
8. Ross' NS. Epidemiology of Cushing's syndrome and subclinical disease. Endocrinol Metab Clin North Am 1994; 23: 539-46.
9. Reincke Martin. Subclinical Cushing's syndrome. Endocrinol Metab Clin North Am 2000; 29: 43-56.
10. Rossi R, Tauchmanova L, Luciano A, et al. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features. J Clin Endocrinol Metab 2000; 85: 1440-8.
11. Azziz R, Dewailly D, Owerbach D. Nonclassic adrenal hyperplasia: current concepts. J Clin Endocrinol Metab 1994; 78: 810-815.
12. Kudva YC, Young WF, Thompson GB, Grant CS, van Heerden JA. Adrenal incidentaloma: an important component of the clinical presentation spectrum of benign sporadic adrenal pheochromocytoma. Endocrinologist 1999; 9: 77-80.
13. Raber W, Raffesberg W, Kmen, E., et al. Pheochromocytoma with normal urinary and plasma catecholamines but elevated plasma free metanephrines in a patient with adrenal incidentaloma. Endocrinologist 2000; 10: 65-8.
14. Lenders JW, Pacak K, Walther MM, et al. Biochemical diagnosis of pheochromocitoma: which test is best? JAMA 2002; 287: 1427-34.
15. Mannelli M, Pupilli C, Lanzillotti R, et al. A nonsecreting pheochromocytoma presenting as an incidental mass. Report on a case. J Endocrinol Invest 1993; 16: 817-22.
16. St. John Sutton, MG, Sheeps SG, Lie JT. Prevalence of clinically unsuspected pheocromocytoma. Review of a 50-year autopsy series. Mayo Clin Proc 1981; 56: 354-60.
17. Fink IJ, Reinig JW, Dwyer AJ, Doppman JL, Linehan WM, Keiser HR. MR imaging of pheochromocytomas. 1985; J Comp Assist Tomogr 9: 454-8.
18. Shapiro B, Copp JE, Sisson JC, Eyre PL, Wallis J, Beierwaltes WH. Iodine-131 metaiodobenzilguanidine for the locating of suspected pheochromocytoma: experience of 400 cases. J Nucl Med 1985; 25: 576-85.
19. Terzolo M, Pia A, Ali A, et al. Adrenal incidentaloma: a new cause of the metabolic syndrome? J Clin Endocrinol Metab 2002; 87: 998-1003.
20. Fernandez-Real JM, Gonzalbez J, Ricart W. Metabolic abnormalities in patients with adrenal incidentaloma. J Clin Endocrinol Metab 2000; 85: 1440-8.
21. Tauchmanova L, Rossi R, Biondi B, et al. Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk. J Clin Endocrinol Metab 2002; 87: 4872-8.
22. Aron D. Adrenal incidentalomas and glucocorticoid autonomy (Commentary). Clin Endocrinol 1998; 49: 157-8.
23. Tsagarakis S, Roboti C, Kokkoris P, Vasiliou V, Alevizaki C, Thalassinos N. Elevated post-dexametasone suppression cortisol concentrations correlate with hormonal alterations of the hypothalamo-pituitary adrenal axis in patients with incidentalomas. Clin Endocrinol 1998; 49: 165-71.
24. Laudat MH, Billaud L, Thomopoulos P, Vera O, Yllia A, Luton JP. Evening urinary free corticoids: a screening test in Cushing's syndrome and incidentally discovered adrenal tumors. Acta Endocrinol 1988; 119: 459-64.
25. Grumbach MM, Biller BM, Braunstein GD, Campbell KK, Carney JA, Godley PA, et al. Management of the clinically inapparent adrenal mass ("incidentaloma"). Ann Intern Med 2003; 138: 424-29.
26. Tanabe A, Naruse M, Nishikawa T, et al. Autonomy of cortisol secretion in clinically silent adrena: incidentaloma. Horm Metab Res 2001; 33:444-50.
27. Young, WF. Jr. Management Approaches to Adrenal Incidentalomas. A view from Rochester, Minnesota. Endocrinol Metab Clin North Am 2000; 29: 159-84.
28. Terzolo M, Osella G, Ali A, et al. Subclinical Cushing's syndrome in adrenal incidentaloma. Clin Endocrinol 1998; 48: 89-97.
29. Bencsik Z, Szabolcs I, Kovacs Z, et al. Low dehydroepiandrosterone sulfate (DHEA-S) is not a good predictor of hormonal activity in non selected patients with incidentally detected adrenal tumors. J Clin Endocrinol Metab 1996; 81: 1726-9.
30. Stratakis CA, Chrousos GP. Adrenal cancer. Endocrinol Metab Clin North Am 2000; 29: 15-25.
31. Jaresch S, Kornely E, Kley HK, Schlaghecke R. Adrenal incidentaloma and patients with homozygous or heterozygous congenital adrenal hyperplasia. J Clin Endocrinol Metab 1992; 74: 685-9.
32. Merke DP, Bornstein S, Braddock D, Chrousos GP. Adrenal limphocytic infiltration and adrenocortical tumors in patients with 21-hydroxylase deficiency. N Eng J Med 1999; 340: 1121-2.
33. Del Monte P, Bernasconi D, Bertolazzi L, et al. Increased 17a-hydroxyprogesterone response to ACTH in silent adrenal adenoma: cause or effect? Clin Endocrinol 1995; 42: 273-7.
34. Kjellman M, Holst M, Backdahl M, Larsson C, Farnebo LO, Wedell A. No overrepresentation of congenital adrenal hyperplasia in patients with adrenocortical tumors. Clin Endocrinol 1999; 50: 343-6.
35. Mantero F and Arnaldi G. Management Approaches to Adrenal Incidentalomas. A view from Ancona, Italy. Endocrinol Metab Clin North Am 2000; 29: 107-24.
36. Gordon RD, Stowasser M, Tunny TJ, Klemm SA, Rutherford JC. High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol 1994; 4: 315-8.
37. Bornstein SR, Stratakis CA, Chrousos GP. Adrenocortical tumors: recent advances in basic concepts and clinical management. Ann Intern Med 1999; 130: 759-71.
38. Katz RL, Shirkhoda A. Diagnostic approach to incidental adrenal nodules in the cancer patient. Results of the clinical, radiological, and fine needle aspiration study. Cancer 1985; 55: 1995-2000.
39. Lee JE, Evans DB, Hickey RC, et al. Unknown primary cancer presenting as an adrenal mass: frequency and implications for diagnostic evaluation of adrenal incidentalomas. Surgery 1998; 124: 1115-22.
40. Caoili EM, Korobkin M, Francis IR, et al. Adrenal masses: characterization with combined unenhanced and dilayed enhanced CT. Radiology 2002; 222: 629-33.
41. Bilbey JH, McLoughlin RF, Kurkjian PS, Wilkins GE, Chan NH, Schmidt N, et al. MR imaging of adrenal masses: value of chemical-shift imaging for distinguishing adenomas from other tumors. AJR Amer J Roentgenol 1995; 164: 637-42.
42. Heinz-Peer G, Honigschnabl S, Niederle B, Lechner G. Characterization of adrenal gland space-occupying lesions. Can diagnostic imaging replace biopsy? Radiologe 1999; 7: 578-83.
43. Latronico AC, Chrousos GP. Extensive personal experience: adrenocortical tumors. J Clin Endocrinol Metab 1997; 5: 1317-24.
44. Bourdeau I, D'Amour P, Hamet P, Boutin JM, Lacroix A. Aberrant membrane hormone receptors in incidentally discovered macronodular adrenal hyperplasia with subclinical Cushing's syndrome. J Clin Endocrinol Metab 2001; 86: 5534-40.
45. Washburn RG, Bennett JE. Reversal of adrenal glucocorticoid dysfunction in a patient with a disseminated histoplasmosis. Ann Intern Med 1989; 110: 86-7.
46. Winfield HN, Hamilton BD, Bravo EL, Novick AC, Laparoscopic adrenalectomy: the preferred choice? A comparison to open adrenalectomy. J Urol 1998; 160: 325-9.
47. Wells SA, Merke DP, Cutler GB Jr, Norton JA, Lacroix A. The role of laparoscopic surgery in adrenal disease. J Clin Endocrinol Metab 1998; 83: 3041-9.
48. Barzon L, Scaroni C, Sonino N, Fallo F, Paoletta A, Boscaro M. Risk factors and long-yerm follow-up of adrenal incidentalomas 1999; J Clin Endocrinol Metab 84: 520-6.
49. Barzon L, Fallo F, Sonino N, Boscaro M. Development of overt Cushing's syndrome in patients with adrenal incidentaloma. Eur J Endocrinol 2002; 146: 61-6.